1. Staubitz-Vernazza, Julia I, Müller, Celine, Heymans, Antonia, Musholt, Thomas J, Hartmann, Nils. . Gene Expression Profiles of AHNAK2, DCSTAMP, FN1, and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma. In Genes, chromosomes & cancer, 63, e23256. doi:10.1002/gcc.23256. https://pubmed.ncbi.nlm.nih.gov/39193983/
2. Zeng, Xiang-zhou, He, Long-gang, Wang, Song, Li, Xiao-juan, Liu, Shu-wen. 2015. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. In Acta pharmacologica Sinica, 37, 255-63. doi:10.1038/aps.2015.85. https://pubmed.ncbi.nlm.nih.gov/26592521/
3. Zeng, Xiang-Zhou, Zhang, Yue-Yang, Yang, Qin, Liu, Shu-Wen, Li, Xiao-Juan. 2019. Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway. In Acta pharmacologica Sinica, 41, 229-236. doi:10.1038/s41401-019-0289-6. https://pubmed.ncbi.nlm.nih.gov/31431733/
4. . 2020. Expression of Concern. In Cellular microbiology, 22, e13259. doi:10.1111/cmi.13259. https://pubmed.ncbi.nlm.nih.gov/33001519/
5. Sultana, M A, Pavlos, N J, Ward, Lynley, Walsh, J P, Rea, S L. 2019. Targeted sequencing of DCSTAMP in familial Paget's disease of bone. In Bone reports, 10, 100198. doi:10.1016/j.bonr.2019.100198. https://pubmed.ncbi.nlm.nih.gov/30886882/
6. Anuj, Anuj, Reuven, Nina, Roberts, Stefan G E, Elson, Ari. 2023. BASP1 down-regulates RANKL-induced osteoclastogenesis. In Experimental cell research, 431, 113758. doi:10.1016/j.yexcr.2023.113758. https://pubmed.ncbi.nlm.nih.gov/37619639/
7. Mullin, Benjamin H, Zhu, Kun, Brown, Suzanne J, Walsh, John P, Wilson, Scott G. 2019. Genetic regulatory mechanisms in human osteoclasts suggest a role for the STMP1 and DCSTAMP genes in Paget's disease of bone. In Scientific reports, 9, 1052. doi:10.1038/s41598-018-37609-0. https://pubmed.ncbi.nlm.nih.gov/30705363/
8. Lee, Jie-Jen, Hsu, Yi-Chiung, Huang, Wen-Chien, Cheng, Shih-Ping. 2023. Upregulation of dendrocyte-expressed seven transmembrane protein is associated with unfavorable outcomes in differentiated thyroid cancer. In Endocrine, 81, 513-520. doi:10.1007/s12020-023-03364-0. https://pubmed.ncbi.nlm.nih.gov/37058220/
智鼠故事 
